Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Feb 21.

Published in final edited form as: J Thorac Oncol. 2012 Jan;7(1):90–97. doi: 10.1097/JTO.0b013e31823c5c32

(A) Stage-adjusted progression- or recurrence-free survival (PFS/RFS) survival curves for immunohistochemistry (IHC)3+ (positive) versus IHC0/1+ (negative) cases.^a (B) Stage-adjusted PFS/RFS survival curves for fluorescence in-situ hybridization (FISH)-positive and FISH-negative cases.^a (C) Stage-adjusted PFS/RFS survival curves for FISH+/IHC3+ (positive) and FISH-negative/IHC0/1+ (negative) cases^a

^aTable 2 Select model data

(A) Stage-adjusted progression- or recurrence-free survival (PFS/RFS) survival curves for immunohistochemistry (IHC)3+ (positive) versus IHC0/1+ (negative) cases.^a (B) Stage-adjusted PFS/RFS survival curves for fluorescence in-situ hybridization (FISH)-positive and FISH-negative cases.^a (C) Stage-adjusted PFS/RFS survival curves for FISH+/IHC3+ (positive) and FISH-negative/IHC0/1+ (negative) cases^a

^aTable 2 Select model data